What oth­er biotech news have you been miss­ing? A big Chi­na IPO and more

Af­ter the Hong Kong ex­change saw the first slate of biotech IPOs plunge well be­low their de­but price, the in­vest­ment crowd got more than a lit­tle wor­ried about what the fu­ture held for oth­er Chi­nese play­ers look­ing to raise cash. But Shang­hai Jun­shi Bio­sciences has helped ease the fret­ting — for now — af­ter watch­ing its stock leap on their roll­out Mon­day.

Ac­cord­ing to Reuters the com­pa­ny raised close to $400 mil­lion and then cheered on a 22% surge in their stock price. And that fol­lows a suc­cess­ful launch for In­novent, an­oth­er pre­mier Chi­na biotech, which has al­so seen a surge since their IPO some weeks ago.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.